Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis

Author： Tawbi H. A.   Beumer J. H.   Tarhini A. A.   Moschos S.   Buch S. C.   Egorin M. J.   Lin Y.   Christner S.   Kirkwood J. M.  

Publisher： Oxford University Press

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.4, 2013-04, pp. : 1112-1119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma

By Mita Monica   Rowinsky Eric   Forero Leonardo   Eckhart S.   Izbicka Elzbieta   Weiss Geoffrey   Beeram Muralidhar   Mita Alain   Bono Johann   Tolcher Anthony   Hammond Lisa   Simmons Paul   Berg Kristin   Takimoto Chris   Patnaik Amita  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 2, 2007-02 ,pp. : 165-174

Springer Publishing Company

Access to resources Recommend Favorite

Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2-positive breast cancer: an NSABP Foundation Research Program phase I study

By Jankowitz Rachel   Abraham Jame   Tan Antoinette   Limentani Steven   Tierno Marni   Adamson Laura   Buyse Marc   Wolmark Norman   Jacobs Samuel  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1205-1212

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer

By Goto Ayumu   Yamada Yasuhide   Hosokawa Ayumu   Ura Takashi   Arai Tatsuhiro   Hamaguchi Tetsuya   Muro Kei   Shimada Yasuhiro   Shirao Kuniaki  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 364-368

Springer Publishing Company

Access to resources Recommend Favorite

Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial

By Ott Patrick   Chang Jason   Madden Kathleen   Kannan Rajni   Muren Caroline   Escano Crystal   Cheng Xin   Shao Yongzhao   Mendoza Sandra   Gandhi Alex   Liebes Leonard   Pavlick Anna  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 183-191

Springer Publishing Company

Access to resources Recommend Favorite

Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer

By Albanell Joan  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 43-44

Informa Healthcare

Access to resources Recommend Favorite